Illumina, Inc. (ILU)
XETR
Real-time Data
07:00 AM
Day's Range
184.0052 wk Range
77.67Overview - ILU - Illumina, Inc.
Key Statistics
Valuation
Enterprise Value
25.11B
P/E (Trailing)
‪40.72‬
PEG Ratio
‪-5.05‬
Price / Sales (TTM)
‪6.28‬
Price / Book
‪11.48‬
EV / EBITDA
‪25.39‬
Profitability
Profit Margin
‪18.33%‬
Operating Margin
‪21.13%‬
Return on Assets
‪8.66%‬
Return on Equity
‪32.33%‬
Ownership
Shares Outstanding
151.00M
Float
149.15M
Held by Insiders
‪0.19%‬
Held by Institutions
‪105.90%‬
Price stats
Beta
‪1.46‬
50-Day Avg
‪154.75‬
200-Day Avg
‪119.38‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - ILU - Illumina, Inc.
Peers - ILU - Illumina, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XETR.
- ILUXETRIllumina, Inc.27.97BMarket Cap+53.64%52-week change35.37P/E (Trailing)‪18.33%‬Profit Margin
- DAPXETRDanaher Corporation129.84BMarket Cap+3.08%52-week change38.88P/E (Trailing)‪15.94%‬Profit Margin
- IX1XETRIDEXX Laboratories, Inc.36.87BMarket Cap-17.58%52-week change39.69P/E (Trailing)‪25.03%‬Profit Margin
- QTSXETRIQVIA Holdings Inc.36.60BMarket Cap+28.69%52-week change128.15P/E (Trailing)‪8.09%‬Profit Margin
- MTOXETRMettler-Toledo International Inc.24.48BMarket Cap+9.45%52-week change32.16P/E (Trailing)‪21.90%‬Profit Margin
- ESF0XETREurofins Scientific SE12.53BMarket Cap+5.09%52-week change25.24P/E (Trailing)‪7.17%‬Profit Margin
- NN6XETRNanoRepro AG23.33MMarket Cap-5.62%52-week change7.39P/E (Trailing)‪-45.83%‬Profit Margin
Profile Summary - ILU - Illumina, Inc.
About
Illumina, Inc. is a life sciences and diagnostics company that develops, manufactures, and markets tools and integrated systems for the analysis of genetic material. Its primary focus is on next-generation sequencing technologies, providing high-throughput and lower-throughput sequencing instruments, consumables, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
